2-hydrazinobenzothiazole has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bairwa, VK; Bellubi, A; Satardekar, K; Telvekar, VN | 1 |
| Bairwa, VK; Telvekar, VN | 1 |
2 other study(ies) available for 2-hydrazinobenzothiazole and Koch's Disease
| Article | Year |
|---|---|
Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents.
Topics: Antitubercular Agents; Benzothiazoles; Chemistry, Pharmaceutical; Drug Design; Escherichia coli; Humans; Hydrazines; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Models, Chemical; Mycobacterium; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Structure-Activity Relationship; Tuberculosis | 2012 |
Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles; Tuberculosis | 2013 |